Traws Pharma, Inc. · NASDAQ:TRAW
Perceptive Advisors LLC reported a 9.99% stake in Traws Pharma, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Perceptive Advisors LLC reported a 9.99% stake in Traws Pharma, Inc., 545,197 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 545,197
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 9.99% | 545,197 |
| Joseph Edelman | 9.99% | 545,197 |
| Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 545,197 |
Source
Related
- Traws Pharma, Inc.
- Perceptive Advisors LLC
- Traws Pharma, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 14, 2025
- Schedule 13G · Perceptive Advisors LLC · Jan 8, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Squadron Capital Management LLC · May 15, 2026